Fig. 3From: In vitro and in silico studies of enterobactin-inspired Ciprofloxacin and Fosfomycin first generation conjugates on the antibiotic resistant E. coli OQ866153Time kill kinetics of (A), Fe+3-enterobactin-Ciprofloxacin conjugate (Fe+3-Cnj-1) at 62 µg/ml and (B), Fe+3-enterobactin-Fosfomycin conjugate (Fe.+3-Cnj-2) at 1 mg/ml, compared to their free antibiotics Ciprofloxacin (CPF) and Fosfomycin (Fos), against the E. coli OQ866153Back to article page